Which one is better, Neratinib or Pyrotinib?

Neratinib and Pyrotinib are two drugs used to treat HER2-positive breast cancer. Their effects can vary depending on the specific patient's condition, so it's impossible to generalize which drug is better.

Neratinib is an oral tyrosine kinase inhibitor indicated as a single agent for the treatment of early-stage HER2-positive breast cancer following trastuzumab-based therapy. This helps reduce the risk of recurrence. Neratinib is used in combination with capecitabine to treat HER2-positive breast cancer that is advanced or has spread to other parts of the body (metastatic). This approach is used when at least two other HER2-based breast cancer treatments are no longer effective. Neratinib blocks the growth and spread of breast cancer cells by inhibiting the activity of the HER2 signaling pathway. However, neratinib may cause some side effects, such as diarrhea, nausea, and vomiting.

Pyrotinib is also an oral tyrosine kinase inhibitor used for the treatment of advanced or metastatic breast cancerHER2-positive breast cancer. Pyrotinib inhibits the growth and spread of tumor cells by inhibiting the activity of the HER2 signaling pathway. Pyrotinib may also cause some side effects, such as diarrhea, rash, and fatigue.

NeratinibThe original drug is marketed in China as neratinib maleate tablets and is covered by Class B medical insurance, but reimbursement is limited to patients who meet the indications. SpecificationsThe price of each box of 40mg*180 tablets may be around 7,000 yuan. Generic drugs of neratinib are also sold overseas. The drug ingredients are basically the same as those of the original drug. The price of 40mg*180 tablets produced by Bangladesh pharmaceutical factory may be around 4,000 yuan per box (the price may fluctuate due to the exchange rate). For more information about overseas drugs and specific prices, please consult Yaode Medical Consultant.